Acetylcholinesterase: The "Hub" for Neurodegenerative Diseases and Chemical Weapons Convention.

Biomolecules
Samir F de A CavalcanteTanos C C França

Abstract

This article describes acetylcholinesterase (AChE), an enzyme involved in parasympathetic neurotransmission, its activity, and how its inhibition can be pharmacologically useful for treating dementia, caused by Alzheimer's disease, or as a warfare method due to the action of nerve agents. The chemical concepts related to the irreversible inhibition of AChE, its reactivation, and aging are discussed, along with a relationship to the current international legislation on chemical weapons.

References

Jun 15, 1989·The Biochemical Journal·A Chatonnet, O Lockridge
Oct 1, 1988·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·O Lockridge
May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Jan 1, 1994·Annual Review of Pharmacology and Toxicology·P Taylor, Z Radić
May 6, 1993·Nature·C Macilwain
May 1, 1997·Toxicology and Applied Pharmacology·M NagaoK Iwadate
Aug 1, 1997·Toxicology and Applied Pharmacology·C E MattesK L Dretchen
May 1, 1998·Pharmaceutical Research·R Diaz Brinton, R S Yamazaki
Oct 29, 1998·Medical Hypotheses·Z X Shen
Dec 29, 2000·Drugs·L J Scott, K L Goa
Apr 3, 2001·Nature Reviews. Neuroscience·H Soreq, S Seidman
Feb 9, 2002·BMJ : British Medical Journal·Demetrius EvisonPaul Rice
Jun 21, 2002·The American Journal of the Medical Sciences·Ronald A GreenfieldMichael S Bronze
Jul 19, 2003·The Journal of Biological Chemistry·Yvain NicoletFlorian Nachon
Aug 28, 2003·Lancet Neurology·Elio ScarpiniHoward Feldman
Mar 24, 2004·Journal of Intensive Care Medicine·Sage W Wiener, Robert S Hoffman
Apr 13, 2004·Prehospital and Disaster Medicine·Yasufumi Asai, Jeffrey L Arnold
May 6, 2004·Journal of Molecular Neuroscience : MN·Robert Vassar
Sep 24, 2004·Basic & Clinical Pharmacology & Toxicology·Jirí CabalJ Kassa
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Motohiro Tomizawa, John E Casida
May 24, 2005·Current Opinion in Pharmacology·Israel Silman, Joel L Sussman
Mar 7, 2006·Mini Reviews in Medicinal Chemistry·Kamil KucaKamil Musilek
Aug 1, 2006·Lancet·Kaj BlennowHenrik Zetterberg
Aug 16, 2006·Drugs·Dean M Robinson, Gillian M Keating
Aug 16, 2006·Phytotherapy Research : PTR·Vikas Kumar
Aug 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Edson X AlbuquerqueMichael Adler
Sep 2, 2006·Journal of the Neurological Sciences·Kevin Cannard
Sep 12, 2006·Journal of the Neurological Sciences·N YanagisawaT Nakajima

❮ Previous
Next ❯

Software Mentioned

OPCW

Related Concepts

Related Feeds

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Related Papers

BMJ : British Medical Journal
Demetrius EvisonPaul Rice
BMJ : British Medical Journal
R E Ferner, M D Rawlins
BMJ : British Medical Journal
BMJ : British Medical Journal
L KarallieddeM Carter
© 2021 Meta ULC. All rights reserved